These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35911772)

  • 1. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells.
    Regev O; Kizner M; Roncato F; Dadiani M; Saini M; Castro-Giner F; Yajuk O; Kozlovski S; Levi N; Addadi Y; Golani O; Ben-Dor S; Granot Z; Aceto N; Alon R
    Front Immunol; 2022; 13():849701. PubMed ID: 35911772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
    Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
    Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
    Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
    Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase.
    Yasuda M; Tanaka Y; Tamura M; Fujii K; Sugaya M; So T; Takenoyama M; Yasumoto K
    Cancer Res; 2001 Mar; 61(5):2022-30. PubMed ID: 11280762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs.
    Petrovich E; Feigelson SW; Stoler-Barak L; Hatzav M; Solomon A; Bar-Shai A; Ilan N; Li JP; Engelhardt B; Vlodavsky I; Alon R
    FASEB J; 2016 May; 30(5):1767-78. PubMed ID: 26823454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
    Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
    BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
    Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
    Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
    [No Abstract]   [Full Text] [Related]  

  • 9. Light stimulates IFNgamma-mediated intercellular adhesion molecule-1 upregulation of cancer cells.
    Zhang M; Guo R; Zhai Y; Fu XY; Yang D
    Hum Immunol; 2003 Apr; 64(4):416-26. PubMed ID: 12651068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells.
    Herzfeldt AK; Gamez MP; Martin E; Boryn LM; Baskaran P; Huber HJ; Schuler M; Park JE; Swee LK
    Elife; 2023 Sep; 12():. PubMed ID: 37732732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation.
    Stöth M; Freire Valls A; Chen M; Hidding S; Knipper K; Shen Y; Klose J; Ulrich A; Ruiz de Almodovar C; Schneider M; Schmidt T
    Int J Cancer; 2019 Nov; 145(9):2509-2520. PubMed ID: 31034094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity.
    Kozlovski S; Regev O; Sapoznikov A; Kizner M; Achdout H; Petrovich-Kopitman E; Elkahal J; Addadi Y; Silva Castanheira FVE; Feigelson SW; Kubes P; Erez N; Garbi N; Alon R
    Front Immunol; 2022; 13():1041552. PubMed ID: 36895258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
    Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y
    J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo.
    Blank C; Brown I; Kacha AK; Markiewicz MA; Gajewski TF
    J Immunol; 2005 Mar; 174(6):3416-20. PubMed ID: 15749875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental evidence that carbon-ion radiotherapy utilizes cytotoxic T lymphocyte-mediated anti-tumor immunity for shrinking tumors compared to X-ray therapy.
    Takeshima T; Hirayama R; Hasegawa S
    Biochem Biophys Res Commun; 2024 Jul; 718():150058. PubMed ID: 38729076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.
    Roland CL; Dineen SP; Toombs JE; Carbon JG; Smith CW; Brekken RA; Barnett CC
    Exp Biol Med (Maywood); 2010 Feb; 235(2):263-70. PubMed ID: 20404043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
    Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
    Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.
    Lu D; Wang Y; Zhang T; Wang F; Li K; Zhou S; Zhu H; Yang Z; Liu Z
    J Nanobiotechnology; 2021 Jun; 19(1):175. PubMed ID: 34112200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.